Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study
International Journal of Clinical Pharmacy · 2025-04 · 47 (2) · 423-434
DOI: 10.1007/s11096-024-01847-2 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Clinical Pharmacy, online erschienen am 19.12.2024. Verfasst von Mohammed Gebre Dedefo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia. mohamm…. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions, Pharmacovigilance, Consumer Behavior. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, University of South Australia.
Abstract (Originalsprache)
Background
The application of digital technologies has shown benefits in enhancing pharmacovigilance activities but consumers views on the use of these tools for this purpose are not well described.
Aim
To explore consumers’ views on using digital tools to report adverse drug reactions (ADRs) and identify key features that consumers want in digital tools for ADR reporting.
Method
An online survey was conducted among adults who had taken medicine in the previous six-months in Australia. The development of questions was guided by the Combined Technology Acceptance Model and Theory of Planned Behaviour (C-TAM-TPB) framework. Responses to closed-ended questions were analysed using descriptive statistics and chi-square/Fisher’s exact test, while free-text responses were analysed using qualitative content analysis.
Results
A total of 494 responses were included in the analysis. Eighty-seven percent of respondents preferred using digital tools for reporting ADRs. Consumers indicated a free-text space for describing ADRs (90%) as important or very important features of digital tools for ADR reporting, followed by acknowledgement of their report submission (87%) and receiving summary of previously reported ADRs (87%). Women ( p < 0.001), advanced smartphone users ( p < 0.001), and previous digital healthcare tool users ( p = 0.017) showed higher intention to use digital tools. Consumers emphasized the importance of ease-of-use, accessibility, receiving medicine safety information, feedback, and advice for reporting ADRs via digital tools.
Conclusion
Consumers prefer using digital tools for reporting ADRs and place high value on features such as a free-text space for describing ADRs, acknowledgement of report submissions, and access to summaries of previously submitted reports.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia. mohammed_gebre.dedefo@mymail.unisa.edu.au.
- Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia.
- UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia.
Förderung
- National Health and Medical Research Council
- University of South Australia
Zitieren
APA
Dedefo, M. G., Lim, R., Kassie, G. M., Gebreyohannes, E. A., Salekdeh, N. N., Roughead, E., & Kalisch Ellett, L. (2025). Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study. International Journal of Clinical Pharmacy, 47(2), 423-434. https://doi.org/10.1007/s11096-024-01847-2
Vancouver
Dedefo MG, Lim R, Kassie GM, Gebreyohannes EA, Salekdeh NN, Roughead E, et al. Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study. International Journal of Clinical Pharmacy. 2025;47(2):423-434. doi:10.1007/s11096-024-01847-2
BibTeX
@article{Dedefo2025,
author = {Dedefo, Mohammed Gebre and Lim, Renly and Kassie, Gizat M and Gebreyohannes, Eyob Alemayehu and Salekdeh, Nava Nikpay and Roughead, Elizabeth and Kalisch Ellett, Lisa},
title = {Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study},
journal = {International Journal of Clinical Pharmacy},
year = {2025},
volume = {47},
number = {2},
pages = {423--434},
doi = {10.1007/s11096-024-01847-2}
}
EUVIMED